1. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours
2. , , , , , and , Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes. The Milan Institute Experience. In: Proc. 3rd International Conference on the Adjuvant Therapy of Cancer, Tucson, pp. 435–444, Grune & Stratton, New York (1981).
3. , , , and , Circulating immune complexes: escape mechanism of tumor cell in breast cancer? In: (ed.), Abstracts, 4th International Congress of Immunology of the International Union of Immunological Societies (JUJS), Paris, 1980, Abstract 10.3.06, Amelot, Brionne (1980).
4. , , , and , Circulating immune complexes as markers for human neoplasia. In: and (ed), Markers of diagnosis and monitoring of human cancer, Proc. Serono Symposia, 46, pp. 9–21, Academic Press, London (1982).